Pharsight

Kinevac patents expiration

KINEVAC Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6803046 BRACCO Sincalide formulations
Aug, 2022

(1 year, 7 months ago)

Kinevac is owned by Bracco.

Kinevac contains Sincalide.

Kinevac has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Kinevac are:

  • US6803046

Kinevac is available in injectable;injection dosage forms.

The generics of Kinevac are possible to be released after 16 August, 2022.

Drugs and Companies using SINCALIDE ingredient

Treatment: NA

Dosage: INJECTABLE;INJECTION

More Information on Dosage

KINEVAC family patents

Family Patents